Roivant Sciences Ltd (NASDAQ: ROIV) is 4.45% higher on its value in year-to-date trading and has touched a low of $8.24 and a high of $13.06 in the current 52-week trading range. The question becomes, what are the chances the stock will continue to grow shareholders’ wealth in the market. Here’s what analysts think will happen to its price in the coming time. The ROIV stock was last observed hovering at around $11.62 in the last trading session, with the day’s gains setting it 0.11%.
Currently trading at $11.73, the stock is 1.02% and -0.33% below its SMA20 and SMA50 respectively. However, with a daily trading volume of 2.51 million and changing 0.95% at the moment leaves the stock 5.75% off its SMA200. ROIV registered 21.43% gain for a year compared to 6-month gain of 7.22%. The firm has a 50-day simple moving average (SMA 50) of $11.7578 and a 200-day simple moving average (SMA200) of $11.08955.
3 Tiny Stocks Primed to Explode
The world's greatest investor — Warren Buffett — has a simple formula for making big money in the markets. He buys up valuable assets when they are very cheap. For stock market investors that means buying up cheap small cap stocks like these with huge upside potential.
We've set up an alert service to help smart investors take full advantage of the small cap stocks primed for big returns.
Click here for full details and to join for free
Sponsored
The stock witnessed a -1.43% loss in the last 1 month and extending the period to 3 months gives it a 9.12%, and is -1.26% down over the last 5 days. If we measure the stock’s price variations over the week and the month, we find that the volatility rates stand at 1.90% over the week and 2.26% over the month.
Roivant Sciences Ltd (ROIV) has around 908 employees, a market worth around $8.67B and $158.30M in sales. Current P/E ratio is 2.10. Profit margin for the company is 2991.76%. Distance from 52-week low is 42.27% and -10.15% from its 52-week high. The company has generated returns on investments over the last 12 months (81.76%).
with sales reaching $49.22M over the same period.The EPS is expected to shrink by -114.15% this year, but quarterly earnings will post 45.50% year-over-year.
Roivant Sciences Ltd (ROIV) Top Institutional Holders
395.0 institutions hold shares in Roivant Sciences Ltd (ROIV), with institutional investors hold 105.52% of the company’s shares. The shares outstanding are 806.68M, and float is at 376.18M with Short Float at 13.62%. Institutions hold 74.82% of the Float.
The top institutional shareholder in the company is SB INVESTMENT ADVISERS (UK) LTD with over 71.36 million shares valued at $754.29 million. The investor’s holdings represent 8.8884% of the ROIV Shares outstanding. As of 2024-06-30, the second largest holder is VIKING GLOBAL INVESTORS LP with 69.16 million shares valued at $$730.98 million to account for 8.6137 of the shares outstanding. The other top investors are QVT FINANCIAL LP which holds 66.72 million shares representing 8.3103% and valued at over $705.23 million, while FMR LLC holds 5.7982 of the shares totaling 46.55 million with a market value of $492.05 million.
Roivant Sciences Ltd (ROIV) Insider Activity
The most recent transaction is an insider sale by Venker Eric, the company’s President & COO. SEC filings show that Venker Eric sold 100,000 shares of the company’s common stock on Oct 21 ’24 at a price of $11.65 per share for a total of $1.17 million. Following the sale, the insider now owns 0.62 million shares.
Still, SEC filings show that on Sep 26 ’24, QVT Financial LP (Director by Deputization) disposed off 876,000 shares at an average price of $11.82 for $10.35 million. The insider now directly holds 22,179,358 shares of Roivant Sciences Ltd (ROIV).
